High prevalence of antibodies against circumsporozoite antigen of Plasmodium falciparum without development of symptomatic malaria in travelers returning from sub-Saharan Africa

Journal of Infectious Diseases

Volumn 174, Issue 6, 1996, Pages 1376-1379

  Jelinek, T ^a,b   Loscher T ^a   Nothdurft, H D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Dept of Infect Dis and Trop Med ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION RATE; MALARIA; MALE; NORMAL HUMAN; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL;

EID: 0029829035     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.6.1376     Document Type: Article

References (13)

1. Druilhe P, Pradier O, Marc JP, Miltgen F, Mazier D, Parent G. Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect Immunol 1986;53:393-7.
2. Del Giudice G, Engers HD, Tougne C, et al. Antibodies to the repetitive epitope of Plasmodium falciparum circumsporozoite protein in a rural Tanzanian community: a longitudinal study of 132 children. Am J Trop Med Hyg 1987;36:203-12.
3. Esposito F, Lombardi S, Modiano D, et al. Prevalence and levels of antibodies to the circumsporozoite protein of Plasmodium falciparum in an endemic area and their relationship to the resistance against malaria infection. Trans R Soc Trop Med Hyg 1988;32:827-32.
4. Zavala F, Tam JP, Hollingdale MR, et al. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 1985;228:1436-40.
5. Young JF, Hockmeyer WT, Gross M, et al. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science 1985;228:958-62.
6. Esposito F, Fabrizi P, Provvedi A, Tarli P, Habluetzel A, Lombardi S. Evaluation of an ELISA kit for epidemiological detection of antibodies to Plasmodium falciparum sporozoites in human sera and bloodspot eluates. Acta Trop 1990;47:1-10.
7. Webster UK, Gingrich JB, Wongsrichalai C, et al. Circumsporozoite antibody as a serological marker of Plasmodium falciparum transmission. Am J Trop Med Hyg 1992;47:489-97.
8. Fonte CJ, Bathurst I, Krettli AU. Plasmodium vivax antibodies in individuals exposed during a single malaria outbreak in a non-endemic area. Am J Trop Med Hyg 1991;42:28-35.
9. Kremsner PG, Neifer S, Zotter GM, et al. Prevalence and level of antibodies to the circumsporozoite proteins of human malaria parasites, including a variant of Plasmodium vivax, in the population of two epidemiologically distinct areas in the state of Acre, Brazil. Trans R Soc Trop Med Hyg 1994;86:23-7.
10. Jelinek T, Nothdurft HD, Löscher T. Evaluation of sporozoite antibody testing as a sero-epidemiological method for the retrospective diagnosis of malaria in non-immune travelers. Trop Med Parasitol 1995;46:154-7.
11. Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993;341:1299-303.
12. International travel and health. Geneva: World Health Organization, 1995.
13. Jelinek T, von Sonnenburg F, Löscher T, Kumlien S, Nothdurft HD. Retrospective immunodiagnosis of malaria in non-immune travelers returning from the tropics. J Travel Med 1995;2:225-8.